Stem cell transplant offers hope for patients with multiple sclerosis

Stem cells harvested from a person’s own bone marrow or blood, can safely slow progression of the most common form of the autoimmune disease, multiple sclerosis, or MS as it’s usually known, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.

Revolutionising healthcare: The role of digital twins – Pharmaceutical Technology

Share this article Patient-specific Organ Models Could Be Used To Minimize The Risk Of Side Effects And Provide Personalised Treatments. Credit: Elenabsl Via Shutterstock. In

January 26, 2024

Harnessing lncRNAs for early diagnosis and intervention in acute kidney injury

A new review published in Genes & Diseases on long non-coding RNAs (lncRNAs) highlights their critical role in the development, diagnosis, and potential treatment of

March 11, 2025

Incyte gears up to face FDA once again with more Zynyz data in rare anal cancer

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.